Acquisition by Ciarimboli Dina of 575000 shares of EQRx subject to Rule 16b-3
EQRXDelisted Stock | USD 1.83 0.13 6.63% |
Slightly above 61% of EQRx's investor base is looking to short. The analysis of current outlook of investing in EQRx Inc suggests that many traders are alarmed regarding EQRx's prospects. EQRx's investing sentiment can be driven by a variety of factors including economic data, EQRx's earnings reports, geopolitical events, and overall market trends.
EQRx |
Filed transaction by Eqrx Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
EQRx Fundamental Analysis
We analyze EQRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EQRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EQRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
EQRx is currently under evaluation in target price category among its peers.
EQRx Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EQRx stock to make a market-neutral strategy. Peer analysis of EQRx could also be used in its relative valuation, which is a method of valuing EQRx by comparing valuation metrics with similar companies.
Peers
EQRx Related Equities
IPSC | Century Therapeutics | 3.85 | ||||
RVMD | Revolution Medicines | 1.97 | ||||
CGEM | Cullinan Oncology | 1.83 | ||||
GLUE | Monte Rosa | 1.65 | ||||
KROS | Keros Therapeutics | 1.43 | ||||
LYEL | Lyell Immunopharma | 1.10 | ||||
BPMC | Blueprint Medicines | 0.81 | ||||
ERAS | Erasca | 0.72 | ||||
EWTX | Edgewise Therapeutics | 0.31 | ||||
STOK | Stoke Therapeutics | 0.08 | ||||
PLRX | Pliant Therapeutics | 0.89 | ||||
SANA | Sana Biotechnology | 1.21 | ||||
MLYS | Mineralys Therapeutics, | 1.42 | ||||
BDTX | Black Diamond | 1.59 | ||||
RLAY | Relay Therapeutics | 2.06 | ||||
KYMR | Kymera Therapeutics | 2.21 | ||||
ARVN | Arvinas | 2.66 | ||||
CCCC | C4 Therapeutics | 4.34 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in EQRx Stock
If you are still planning to invest in EQRx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EQRx's history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |